Results 181 to 190 of about 25,999 (347)
We conducted a nationwide, multicenter cohort study using a target trial emulation framework to compare baclofen and acamprosate in patients with compensated alcohol‐associated cirrhosis. After matching, baclofen initiation was associated with a higher 1‐year risk of major adverse liver outcomes, driven primarily by hepatic encephalopathy, particularly
Yee Hui Yeo +13 more
wiley +1 more source
Fatal vincristine-induced acute neurotoxicity mimicking Guillain-Barré syndrome
Illias Tazi +3 more
openalex +1 more source
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy [PDF]
Zhenguang Wang, Weidong Han
openalex +1 more source
Mechanisms of immune effector
Tianning Gu +4 more
openalex +1 more source
An Adverse Outcome Pathway for Potential Space Radiation Induced Neurological Diseases [PDF]
Astronauts have begun to spend increasingly longer periods in space, putting themselves in foreign environments in order to explore the unknown. Space radiation is one of the largest health risks faced by astronauts on their missions. The space radiation
Mi, Kaitlyn, Norman, Ryan B.
core +1 more source
Summary Bridging therapy (BT) prior to brexucabtagene autoleucel (brexu‐cel) in mantle cell lymphoma (MCL) is supported by limited evidence. Here, we report BT modality and outcome in 176 patients at 15 centres in the United Kingdom. BT was delivered to 90% (158/176), the majority receiving standard chemotherapy +/− radiotherapy (53%) (SD chemo +/− RT)
Maeve A. O'Reilly +28 more
wiley +1 more source
Polymyxin-Associated Neurotoxicity: A Case of Guillain-Barré Syndrome Temporally Linked to Colistin Methanesulfonate and Respiratory Paralysis with Polymyxin B. [PDF]
Huang J +6 more
europepmc +1 more source

